RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure

计划入组 72 人 · 首次发布于 2024 年 10 月 29 日

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

计划入组 56 人 · 首次发布于 2018 年 6 月 27 日

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

计划入组 51 人 · 首次发布于 2021 年 8 月 18 日

CDK12 Inhibitor

CDK1/CDK2 modulators (cancer)

CDK12 inhibitors(Syros)

Immunotherapy Shows Promise in Prostate Cancer with MMRd Mutation

Insilico Medicine Develops Novel AI-Designed CDK12/13 Inhibitors for Treatment-Resistant Cancers

Carrick Therapeutics Initiates Phase 1 Trial of Novel CDK12/13 Inhibitor CT7439 in Advanced Solid Tumors